A 59-year-old woman with BMI 43 asks about obesity treatment with GLP-1 receptor agonists and fatty liver. What is accurate?...

Question

A 59-year-old woman with BMI 43 asks about obesity treatment with GLP-1 receptor agonists and fatty liver. What is accurate?

Accepted Answer

GLP-1 RAs improve weight and may benefit MASLD; use per obesity/diabetes indications

Answer

GLP-1 RAs are contraindicated in liver disease

Answer

Only surgery helps MASLD

Answer

GLP-1 RAs worsen liver histology

Answer

They replace lifestyle interventions

us-usmle-step-2 MCQ (SBA): MASLD